| DIRECT COMPETITOR COMPARISON | |
| GHDX | CLRT | GENZ | LIFE | Industry | | Market Cap: | 543.88M | 199.99M | 13.45B | 8.88B | 78.16M | | Employees: | 387 | 340 | 11,000 | 9,700 | 474 | | Qtrly Rev Growth (yoy): | 40.50% | 12.80% | -8.90% | 121.40% | 13.50% | | Revenue (ttm): | 141.20M | 90.28M | 4.61B | 2.95B | 141.20M | | Gross Margin (ttm): | 75.88% | 58.86% | 72.40% | 64.07% | 47.15% | | EBITDA (ttm): | -5.46M | 2.96M | 1.63B | 818.22M | 8.84M | | Oper Margins (ttm): | -8.32% | -0.36% | 26.10% | 15.72% | 7.12% | | Net Income (ttm): | -11.40M | -10.77M | 485.70M | 7.87M | N/A | | EPS (ttm): | -0.400 | -0.131 | 1.754 | 0.049 | 0.03 | | P/E (ttm): | N/A | N/A | 28.91 | 1015.92 | 22.87 | | PEG (5 yr expected): | N/A | N/A | 1.03 | 1.48 | 1.44 | | P/S (ttm): | 3.84 | 2.04 | 2.94 | 3.02 | 1.78 |
|
| CLRT = Clarient, Inc. | | GENZ = Genzyme Corp. | | LIFE = Life Technologies Corporation | | Industry = Medical Laboratories & Research | |
| NEWS ON DIRECT COMPETITORS | |
| | CLRT | | AIG, Las Vegas Sands, US Bancorp are big movers Mon 4:53pm -
AP | | | GENZ | | 'Black Friday' Data Weighs on Futures Mon 11:29am -
at Seeking Alpha | | | LIFE | | Luminex Posts Loss Mon 10:14am -
Zacks.com | | | CLRT | | Clarient gains license for cancer test technology Mon 10:03am -
AP | | | GENZ | | Baidu: Analysts' Upgrades, Dowgrades Mon 9:30am -
at TheStreet.com | | | GENZ | | Genzyme upgraded by Citigroup Mon 6:29am -
Briefing.com | | | CLRT | | InPlay: Clarient granted exclusive license to commercialize cancer biomarker by Minerva Biotechnologies Mon 6:13am -
Briefing.com | | | CLRT | | Clarient Granted Exclusive License to Commercialize Cancer Biomarker by Minerva Biotechnologies Mon 6:00am -
PR Newswire | | | GENZ | | Biotech Stock Mailbag: Targacept Fri, Nov 27 -
at TheStreet.com | | | GENZ | | Genzyme CEO Termeer Sells Company Shares Wed, Nov 25 -
at Fox Business | | | GENZ | | Dream Stocks for Biotech Investors Wed, Nov 25 -
at Motley Fool | | | LIFE | | InvestorSoup.com Issues Technical Trading Outlook for ARCA biopharma Inc. Wed, Nov 25 -
GlobeNewswire | | | CLRT | | 4-Star Stocks on the Upswing Tue, Nov 24 -
at Motley Fool | | | LIFE | | Uncertainty Breeds Opportunity in Specialty Pharma Stock Pick From Piper Jaffray Senior Research Analyst Fri, Nov 20 -
Wall Street Transcript | | | LIFE | | Beacon Equity Issues Technical Trading Overview for Questcor Pharmaceuticals Inc. Thu, Nov 19 -
GlobeNewswire | | | LIFE | | LIFE TECHNOLOGIES CORP Files SEC form 8-K, Unregistered Sale of Equity Securities Fri, Nov 13 -
EDGAR Online | | | LIFE | | Desktop Bug Detector Thu, Nov 12 -
at Forbes.com | | | All Headlines for these symbols... |
|
|
|